Increased Frequency of Dysfunctional Siglec-7−CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease
暂无分享,去创建一个
T. Honda | Takanori Ito | Y. Osawa | Taizo Mori | Sachiyo Yoshio | T. Kanto | A. Saiura | A. Taketomi | Y. Mise | Yu Takahashi | Y. Sakamoto | Yoshihiko Aoki | Hironari Kawai | Shiori Yoshikawa | M. Matsuda | Tomonari Shimagaki | M. Atsukawa | H. Doi | N. Itokawa | Y. Yoshida | Taeang Arai | Y. Ono | T. Arai | Y. Takahashi
[1] A. Lohse,et al. Characterization of the immune cell landscape of patients with NAFLD , 2020, PloS one.
[2] G. Mellgren,et al. Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease , 2019, Front. Immunol..
[3] Clara Di Vito,et al. Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology , 2019, Front. Immunol..
[4] M. Shong,et al. T-cell senescence contributes to abnormal glucose homeostasis in humans and mice , 2019, Cell Death & Disease.
[5] Lifen Gao,et al. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication , 2018, Front. Immunol..
[6] Leo Swadling,et al. IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction , 2018, Front. Immunol..
[7] D. Margolis,et al. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo , 2018, Journal of Virology.
[8] E. Sahai,et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control , 2018, Cell.
[9] Abigail K Kimball,et al. A Beginner’s Guide to Analyzing and Visualizing Mass Cytometry Data , 2018, The Journal of Immunology.
[10] Vincent Wai-Sun Wong,et al. New trends on obesity and NAFLD in Asia. , 2017, Journal of hepatology.
[11] H. Kielstein,et al. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans , 2017, Immunologic Research.
[12] Y. Cheng,et al. Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers , 2017, Oncogene.
[13] C. Mantzoros,et al. Adipose tissue, obesity and non-alcoholic fatty liver disease. , 2017, Minerva endocrinologica.
[14] C. Dumontet,et al. Alteration of Natural Killer cell phenotype and function in obese individuals. , 2017, Clinical immunology.
[15] Liang Chen,et al. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease , 2017, Oncotarget.
[16] Sun-Hee Kim,et al. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. , 2017, Human immunology.
[17] H. Lee,et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. , 2017, Journal of hepatology.
[18] D. Olive,et al. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma , 2016, Oncotarget.
[19] H. Ljunggren,et al. Emerging insights into natural killer cells in human peripheral tissues , 2016, Nature Reviews Immunology.
[20] E. Wisse,et al. Liver natural killer cells: subsets and roles in liver immunity , 2015, Cellular and Molecular Immunology.
[21] N. Leitinger,et al. NKp46+ natural killer cells attenuate metabolism‐induced hepatic fibrosis by regulating macrophage activation in mice , 2015, Hepatology.
[22] G. Ferraioli,et al. Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection , 2015, Gut.
[23] E. Bjornsson,et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.
[24] G. Cooke,et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.
[25] Cheng-song Sun,et al. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy , 2015, Acta Pharmacologica Sinica.
[26] B. Sangro,et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] L. Hübner,et al. Altered NK cell function in obese healthy humans , 2015, BMC Obesity.
[28] J. Boscarino,et al. The validity of serum markers for fibrosis staging in chronic hepatitis B and C , 2014, Journal of viral hepatitis.
[29] H. Moch,et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. , 2014, Cancer cell.
[30] P. Romero,et al. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. , 2014, The Journal of clinical investigation.
[31] Stephen M. Canham,et al. Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion , 2013, Nature chemical biology.
[32] E. Riley,et al. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..
[33] Z. Tian,et al. Natural killer cells in liver disease , 2013, Hepatology.
[34] Sumati Rajagopalan,et al. Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.
[35] J. Lord,et al. Reduced release and binding of perforin at the immunological synapse underlies the age‐related decline in natural killer cell cytotoxicity , 2012, Aging cell.
[36] S. Ludovisi,et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection , 2012, Hepatology.
[37] K. Cusi,et al. Corrigendum:The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.
[38] K. Cusi,et al. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.
[39] P. Crocker,et al. CD33‐related siglecs as potential modulators of inflammatory responses , 2012, Annals of the New York Academy of Sciences.
[40] I. Ng,et al. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma , 2011, Gut.
[41] A. Baranova,et al. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.
[42] C. Lutz,et al. Human NK Cells Proliferate and Die In Vivo More Rapidly than T Cells in Healthy Young and Elderly Adults , 2011, The Journal of Immunology.
[43] H. Pircher,et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.
[44] M. Caligiuri,et al. The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. , 2010, Blood.
[45] A. Órfão,et al. Chronic alcohol consumption is associated with an increased cytotoxic profile of circulating lymphocytes that may be related with the development of liver injury. , 2010, Alcoholism, clinical and experimental research.
[46] L. Lynch,et al. Natural Killer Cells in Obesity: Impaired Function and Increased Susceptibility to the Effects of Cigarette Smoke , 2010, PloS one.
[47] D. Focosi,et al. CD57+ T lymphocytes and functional immune deficiency , 2010, Journal of leukocyte biology.
[48] A. Moretta,et al. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.
[49] G. Michelone,et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.
[50] P. Tien,et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. , 2008, Clinical immunology.
[51] B. Bochner,et al. Basic and Clinical Immunology of Siglecs , 2008, Annals of the New York Academy of Sciences.
[52] Ajit Varki,et al. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins , 2007, Nature.
[53] Ajit Varki,et al. Siglecs and their roles in the immune system , 2007, Nature Reviews Immunology.
[54] J. Montaner,et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.
[55] R. Sun,et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.
[56] A. Varki,et al. Siglecs--the major subfamily of I-type lectins. , 2006, Glycobiology.
[57] C. Lutz,et al. Reciprocal age related change in natural killer cell receptors for MHC class I , 2005, Mechanisms of Ageing and Development.
[58] R. Vaughan,et al. Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique , 2005, Laboratory Investigation.
[59] D. Doherty,et al. Hepatic interleuklin 15 (IL‐15) expression: implications for local NK/NKT cell homeostasis and development , 2004, Clinical and experimental immunology.
[60] R. Groszmann,et al. American association for the study of liver diseases , 1992 .
[61] Mark J. Smyth,et al. Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.
[62] T. Imperiale,et al. Clinical utility of the AST/ALT ratio in chronic hepatitis C , 2001, American Journal of Gastroenterology.
[63] L. Lanier,et al. Immune inhibitory receptors. , 2000, Science.
[64] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[65] C. Caruso,et al. Granulocyte and natural killer activity in the elderly , 1999, Mechanisms of Ageing and Development.
[66] D. Sgroi,et al. Siglecs: a family of sialic-acid binding lectins. , 1998, Glycobiology.